3Boos J,Werber G,Ahlke E,et al.Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.Eur J Cancer,1996,32A:1544-1550.
4Vieira Pinheiro JP,Lanversa C,Wurthwein G,et al.Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin' s lymphoma.Leuk Lymphoma,2002,43:1911-1920.
5Rizzari C,Valsecchi MG,Arico M,et al.Effect of protracted highdose L-Asparaginase given as a second exposure in a Berlin-FrankfurtMunster-based treatment:results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.J Clin Oncol,2001,19:1297-1303.
6Albertsen BK,Schroder H,Jakobsen P,et al.Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries.Br J Clin Pharmaco1,2001,52:433-437.
7Riccardi R,Holcenberg JS,Glaubiger DL,et al.L-Asparaginase pharmacokinetics and asparagines levels in cerebrospinal fluid of rhesus monkeys and humans.Cancer Res,1981,41:4554-4558.
8张之南 杨天楹 郝玉书.等血液病学[M].北京:人民卫生出版社,2003.1008.
9Sandlund JT, Downing JR, Grist WM. Non-Hodgkin's Lymphoma in childhood[J]. N EnglJ Med, 1996, 334(19):1238～1248.
10Pinkerton GR. The continuing challenge of treatnent for nonHodgkin's lymphoma in children[J]. BrJ Haematol, 1999, 107(2):220～234.
